Home / Therapies / Blood Glucose Control (page 15)

Blood Glucose Control

When GLP-1 Therapy Plateaus: What Clinicians Should Do Next

Clinician reviewing patient progress during a GLP-1 plateau with metabolic trend chart on computer screen

Everything seems to be working perfectly until it suddenly isn’t. A patient is losing weight steadily, HbA1c levels are improving, and confidence is high during every follow-up visit. Then progress slows. The scale barely changes. Blood sugar readings stop improving. Patients start asking whether the medication has stopped working, while …

Read More »

Early Use of GLP-1 Therapy: Are We Starting Treatment Too Late in Diabetes Care?

Clinician holding GLP-1 injection pen with glucose monitor and heart health symbols representing early diabetes treatment

What if the biggest missed opportunity in diabetes care is not a new drug, but when we start using it? Early GLP-1 therapy is gaining attention as clinicians rethink traditional treatment timelines. Instead of reserving GLP-1 receptor agonists for later stages, emerging evidence suggests starting sooner may improve outcomes and …

Read More »

Managing Rapid Improvement on GLP-1 Therapy: When to Adjust the Rest of the Regimen

Diabetes management tools including glucometer showing improved glucose levels, insulin pen, and medication plan for GLP-1 therapy adjustment

Rapid glycemic improvement with GLP-1 therapy is one of the most powerful benefits of modern diabetes care, but it can also create new clinical challenges. When glucose levels drop quickly, patients may face an increased risk of hypoglycemia if other medications are not adjusted in time. So, how do clinicians …

Read More »

Diabetes Treatment Persistence: Why Patients Stop Therapy and What Clinicians Can Do

Doctor discussing diabetes treatment plan and adherence strategies with a patient during a clinical consultation

Why do so many patients begin treatment with good intentions, only to fall off track later? Staying consistent with diabetes treatment continues to challenge both patients and clinicians despite medical advances. While new therapies offer better control, long-term success still depends on consistency. However, many patients struggle to maintain routines, …

Read More »

Continuous Ketone Monitoring in Hospital Care: Could It Improve DKA Management?

Continuous ketone monitoring device on a patient in a hospital with clinician reviewing real-time ketone and glucose readings

Diabetic ketoacidosis remains one of the most serious complications of diabetes, yet managing it often relies on intermittent data points. What if clinicians could see ketone levels change in real time instead of waiting hours between lab tests? Continuous ketone monitoring for DKA is now emerging as a promising concept …

Read More »

When Metabolic Improvements Occur Without Weight Loss: How Should Clinicians Respond?

GLP-1 medication pen with glucose monitor and medical tools illustrating metabolic health without weight loss

Can a therapy improve metabolic health even if the scale does not budge? This question is becoming increasingly relevant as clinicians observe patients benefiting from GLP-1 therapy even without significant weight loss. While weight reduction has long been a primary goal of incretin-based therapies, emerging data suggest that metabolic improvements …

Read More »

Hyperglycemia in Oncology Care: Applying New Guidance in Clinical Practice

Oncologist reviewing elevated blood glucose reading during cancer treatment in a clinical setting

Managing hyperglycemia in oncology patients is becoming a critical part of cancer care, especially as newer therapies affect glucose metabolism. Have you ever wondered why patients with no history of diabetes suddenly develop high blood sugar during treatment? This growing challenge highlights the need for structured, practical approaches. In this …

Read More »

When Diabetes Metrics Conflict: What to Do When A1C, CGM, and Symptoms Don’t Align

Comparison of A1C report, CGM readings, and glucometer showing conflicting diabetes metrics on a clinical desk

When diabetes metric discordance shows up in clinical practice, it can feel like trying to read three clocks that all tell different times. A1C suggests one story, continuous glucose monitoring points to another, and patient symptoms may not match either. So how should clinicians respond when these signals conflict? Understanding …

Read More »

GLP-1 Therapy and Diagnostic Drift: Are We Masking Disease Progression?

GLP-1 injection pen with HbA1c test tubes and pancreas model illustrating hidden diabetes disease progression

Disease progression in patients using GLP-1 therapies is becoming a critical topic as these medications continue to reshape diabetes care. While GLP-1 receptor agonists improve glycemic control and support weight loss, could they also be hiding deeper metabolic decline? Much like a polished surface that conceals underlying cracks, improved lab …

Read More »